These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 7736475

  • 21. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration.
    Marenzi G, Grazi S, Giraldi F, Lauri G, Perego G, Guazzi M, Salvioni A, Guazzi MD.
    Am J Med; 1993 Jan; 94(1):49-56. PubMed ID: 8420299
    [Abstract] [Full Text] [Related]

  • 22. Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
    Mulder H, Schopman W, van der Lely AJ, Schopman W.
    Horm Metab Res; 1987 Feb; 19(2):80-3. PubMed ID: 3549504
    [Abstract] [Full Text] [Related]

  • 23. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1322-30. PubMed ID: 18179782
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
    Guazzi M, Pontone G, Trevisi N, Lomanto M, Melzi G, Agostoni P.
    Ann Ital Med Int; 1998 Mar 15; 13(1):17-23. PubMed ID: 9642838
    [Abstract] [Full Text] [Related]

  • 26. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, Modai D.
    Miner Electrolyte Metab; 1996 Mar 15; 22(4):248-52. PubMed ID: 8807629
    [Abstract] [Full Text] [Related]

  • 27. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K.
    Am J Vet Res; 1996 Nov 15; 57(11):1645-52. PubMed ID: 8915446
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul 15; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 30. Indications for ultrafiltration in the cardiac surgical patient.
    Magilligan DJ.
    J Thorac Cardiovasc Surg; 1985 Feb 15; 89(2):183-9. PubMed ID: 3968903
    [Abstract] [Full Text] [Related]

  • 31. [Effect of using nifedipine by patients with chronic congestive heart failure treated with digoxin and furosemide].
    Markiewicz K, Górski L, Cholewa M, Gawor Z, Dryjański T.
    Pol Tyg Lek; 1985 Feb 15; 45(23-24):461-5. PubMed ID: 2277789
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Diuretics as initial and sole treatment in chronic cardiac failure.
    Anand IS, Kalra GS, Harris P, Poole-Wilson PA, Panzali A, De Giuli F, Ferrari R.
    Cardioscience; 1991 Dec 15; 2(4):273-8. PubMed ID: 1760518
    [Abstract] [Full Text] [Related]

  • 34. Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
    Tomiyama H, Watanabe G, Yoshida H, Doba N, Yamashina A.
    Am Heart J; 2003 Jan 15; 145(1):E2. PubMed ID: 12514674
    [Abstract] [Full Text] [Related]

  • 35. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A.
    Clin Pharmacol Ther; 1997 Aug 15; 62(2):187-93. PubMed ID: 9284855
    [Abstract] [Full Text] [Related]

  • 36. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
    Libetta C, Sepe V, Zucchi M, Pisacco P, Cosmai L, Meloni F, Campana C, Rampino T, Monti C, Tavazzi L, Dal Canton A.
    Nephrol Dial Transplant; 2007 Jul 15; 22(7):2013-9. PubMed ID: 17298996
    [Abstract] [Full Text] [Related]

  • 37. The clinical value of digoxin in patients with heart failure and sinus rhythm.
    McHaffie D, Purcell H, Mitchell-Heggs P, Guz A.
    Q J Med; 1978 Oct 15; 47(188):401-19. PubMed ID: 751085
    [Abstract] [Full Text] [Related]

  • 38. [Extracorporeal treatment in patients with heart failure: pathophysiology, indications and results].
    Marenzi G, Marana I, Agostoni P.
    G Ital Nefrol; 2006 Oct 15; 23 Suppl 36():S46-51. PubMed ID: 17068729
    [Abstract] [Full Text] [Related]

  • 39. Neuroendocrine response to cardiac transplantation.
    Masters RG, Davies RA, Keon WJ, Walley VM, Koshal A, de Bold AJ.
    Can J Cardiol; 1993 Sep 15; 9(7):609-17. PubMed ID: 8221359
    [Abstract] [Full Text] [Related]

  • 40. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J, Bech JN, Nyvad O, Jensen P, Pedersen EB.
    Scand J Clin Lab Invest; 2006 Sep 15; 66(1):55-66. PubMed ID: 16464787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.